Lab Study Slows Breast Cancer Spread to Bone in Mice
An experimental drug reduced the spread of breast cancer into bone in mice, researchers say. The drug — Y27632 — inhibits a protein called Rho-associated kinase (ROCK), which is over-produced in...
View ArticleHerceptin Now Approved in the EU for Patients with HER2-Positive Advanced...
First targeted biological therapy to show survival benefit in stomach cancer Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Commission has approved Herceptin (trastuzumab) in...
View ArticleNew First-line Therapy Now Available For Treatment Of Advanced Hormone...
TykerbTM (lapatinib ditosylate) has received Health Canada approval for use in combination with letrozole (an aromatase inhibitor) for the treatment of post-menopausal women with hormone...
View Article
More Pages to Explore .....
